Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-23

FDA Approved: CHILDRENS IBUPROFEN ORAL SUSPENSION, DYE FREE — Original Application (Best Choice)

View source ↗

Summary

FDA approved a dye-free children's ibuprofen oral suspension from Best Choice under an original ANDA, enabling a generic version for fever and pain relief.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHILDRENS IBUPROFEN ORAL SUSPENSION, DYE FREE (Ibuprofen)

Snippet

ORIG AP for CHILDRENS IBUPROFEN ORAL SUSPENSION, DYE FREE (IBUPROFEN)